11/15
06:04 pm
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
11/15
05:41 pm
clsd
Rating for CLSD
Low
Report
Rating for CLSD
11/14
08:15 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
11/13
08:05 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
11/13
06:45 am
clsd
Rating for CLSD
Low
Report
Rating for CLSD
11/13
06:45 am
clsd
Rating for CLSD
Low
Report
Rating for CLSD
10/14
12:46 pm
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
10/14
12:08 pm
clsd
Rating for CLSD
Medium
Report
Rating for CLSD
10/10
05:28 am
clsd
Rating for CLSD
Medium
Report
Rating for CLSD
10/10
05:28 am
clsd
Rating for CLSD
Medium
Report
Rating for CLSD